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Abstract
Decreased mitochondrial function plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (T2DM). Recently, it
was reported that mitochondrial DNA (mtDNA) haplogroups confer genetic susceptibility to T2DM in Koreans and Japanese.
Particularly, mtDNA haplogroup N9a is associated with a decreased risk of T2DM, whereas haplogroups D5 and F are
associated with an increased risk. To examine functional consequences of these haplogroups without being confounded by
the heterogeneous nuclear genomic backgrounds of different subjects, we constructed transmitochondrial cytoplasmic
hybrid (cybrid) cells harboring each of the three haplogroups (N9a, D5, and F) in a background of a shared nuclear genome.
We compared the functional consequences of the three haplogroups using cell-based assays and gene expression
microarrays. Cell-based assays did not detect differences in mitochondrial functions among the haplogroups in terms of ATP
generation, reactive oxygen species production, mitochondrial membrane potential, and cellular dehydrogenase activity.
However, differential expression and clustering analyses of microarray data revealed that the three haplogroups exhibit a
distinctive nuclear gene expression pattern that correlates with their susceptibility to T2DM. Pathway analysis of microarray
data identified several differentially regulated metabolic pathways. Notably, compared to the T2DM-resistant haplogroup
N9a, the T2DM-susceptible haplogroup F showed down-regulation of oxidative phosphorylation and up-regulation of
glycolysis. These results suggest that variations in mtDNA can affect the expression of nuclear genes regulating
mitochondrial functions or cellular energetics. Given that impaired mitochondrial function caused by T2DM-associated
mtDNA haplogroups is compensated by the nuclear genome, we speculate that defective nuclear compensation, under
certain circumstances, might lead to the development of T2DM.
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Introduction
Mitochondrial dysfunction plays a key role in the pathogenesis
of insulin resistance and pancreatic b-cell dysfunction, the two
major pathophysiological defects of type 2 diabetes mellitus
(T2DM) [1,2]. The glucose-stimulated insulin secretion in
pancreatic b-cells is triggered by the closure of ATP-sensitive
potassium channels, which is dependent on intracellular ATP
levels generated from mitochondria [3]. In this regard, it is of note
that the pancreatic b-cell-specific knockout of mitochondrial
transcription factor A results in diabetes due to severe impairment
of insulin secretion and b-cell loss in mice [4]. Insulin resistant
offspring of T2DM patients revealed an approximately 60%
decrease in insulin-stimulated glucose uptake and an approxi-
mately 30% decrease in mitochondrial oxidative phosphorylation
(OXPHOS) capacity in the skeletal muscle [1], implying that
decreased mitochondrial function may also lead to skeletal muscle
insulin resistance. Genome-wide expression analyses have dem-
onstrated that genes involved in mitochondrial OXPHOS were
coordinately down-regulated in the skeletal muscle of T2DM
subjects presumably due to decreased PGC-1a (peroxisome
proliferator-activated receptor c coactivator 1a) expression, which
is a key regulator of mitochondrial function and biogenesis [5,6].
Therefore, it is essential to figure out the causes of mitochondrial
dysfunction to prevent and treat T2DM.
Genetic variations in nuclear DNA or mitochondrial DNA are
known to be associated with decreased b-cell function and/or the
risk of T2DM[5,6,7,8,9,10]. An A to G substitution at nucleotide
position 3243 (A3243G) of mtDNA, which encodes leucyl-
tRNA
UUR, is commonly associated with maternally inherited
diabetes and deafness [3,11]. A common mtDNA polymorphism,
T16189C, is significantly associated with T2DM at least in Asians,
including Koreans, Japanese, and Chinese, with an odds ratio of
1.26 (95% confidence interval 1.08–1.46) [7]. The binding affinity
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the T16189C variant [7], implying that this variant may alter
mitochondrial function. However, the association between the
T16189C variation and T2DM was not evident in Europeans
[12]. Ethnic differences in nuclear and mitochondrial genomic
background as well as environmental factors may explain this
discrepancy. Interestingly, geographic region-specific mtDNA
haplogroups are thought to modify mitochondrial function
because there is evidence that they are formed by adaptation to
thermal environments and subsequent natural selection [13,14].
Contrary to this notion, it was reported that mtDNA haplogroups
were not associated with the risk of T2DM in Europeans [15].
However, it was recently demonstrated that mtDNA haplogroups
are associated with susceptibility to T2DM in both Koreans and
Japanese [10]. Among the 10 most common mtDNA haplogroups
in Koreans and Japanese, the N9a haplogroup was significantly
associated with a decreased risk of T2DM, while haplogroups D5
and F were associated with an increased risk of T2DM [10].
However, the mechanisms by which mtDNA haplogroups N9a,
D5, and F modulate the susceptibility to T2DM still remain
elusive. In this regard, it is noteworthy that conplastic strains of
rats with identical nuclear genomes but divergent mitochondrial
genomes display significant differences in glucose and insulin
response after oral glucose load [16], implying that the
mitochondrial genome per se (or a certain mtDNA haplogroup)
may affect metabolic phenotypes.
To examine functional differences of mtDNA haplogroups
independent of different nuclear genomes from individual subjects,
we took advantage of the transmitochondrial cytoplasmic hybrid
(cybrid) model (Figure 1), which is generated by the fusion of
mtDNA-depleted cells (rho
0) with mtDNA donors (either enucle-
ated cells or platelets) [17]. Platelets, which are formed by the
cytoplasmic budding of megakaryocytes, are suitable as mtDNA
donors because they lack nuclei but contain intact mitochondria
[18]. The merit of using an identical rho
0 cell line as the mtDNA
recipient is to avoid the confounding effects of having different
nuclear genomes from different subjects, which is a major hurdle
when studying tissues from different individuals [19]. Thus, the
cybrid model enables us to isolate the functional consequences of
different mtDNA haplogroups, including altered mitochondrial
function and/or differential expression of nuclear genes induced
by retrograde signaling from mitochondria to nucleus. In the
present study, we compared functional characteristics of cybrid
cells harboring T2DM-resistant haplogroup N9a or T2DM-
susceptible haplogroups D5 and F with cell-based functional
assays. In addition, we performed microarray analyses to examine
differences in gene expression that might arise from the
mitochondria-nuclear interaction.
Materials and Methods
Generation of cybrid cells
The Institutional Review Board of the Clinical Research
Institute at Seoul National University Hospital approved the
study protocol, and written informed consent was obtained from
each subject. To produce cybrid clones, we used platelets from 12
non-diabetic subjects harboring haplogroups D5 (n=3), F (n=5),
and N9a (n=4), selected from our previous study [10]. The
osteosarcoma cell line with neither mtDNA nor thymidine kinase
activity (143B TK
2 r
0) was generously provided by Professor Yau-
huei Wei from National Yang-Ming University, Taipei, Taiwan. It
was obtained after long-term exposure to ethidium bromide
(50 ng/ml) and was grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 100 mg/ml 5-bromodeoxy-
uridine, 50 mg/ml uridine, and 10% fetal bovine serum. Southern
blot analysis and PCR amplification of the mtDNA target
sequences confirmed the absence of any residual mtDNA (data
not shown). Using platelets as mtDNA donors, cybrid cells were
produced as described previously [18] (Figure 1). Briefly, the
platelet-rich fraction was separated by centrifugation from venous
whole blood and fused to 143B TK
2 r
0 cells in the presence of
42% polyethylene glycol 1500 (Sigma-Aldrich, St. Louis, MO).
Sixty seconds after the addition of 42% polyethylene glycol, the
cells were resuspended in DMEM. After twenty-four hours, the
Figure 1. Schematic of cybrid generation and data analysis. (A) Generation of cybrids. Round circle: nucleus, filled ovals: intact mitochondria,
unfilled ovals: mtDNA-depleted mitochondria. (B) Comparison of cybrids originating from three mtDNA haplogroups.
doi:10.1371/journal.pone.0022116.g001
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idine but lacking uridine to select only successfully fused cells. The
reconstitution of mtDNA haplogroups in cybrid cells was
confirmed by restriction fragment length polymorphism specific
to each mtDNA haplogroup (data not shown). To assure a
complete repopulation of mtDNA haplogroups, cell-based func-
tional assays and microarray experiments were carried out after 2–
3 months of successive subcultivation.
Cell-based functional measurements
The detailed methods for cell-based functional assays are
provided in the File S2. In brief, cybrid cells were seeded in 96-
well plates at a density of 1610
6 cells/ml. After stabilization for
24 hours at 37uC under 5% CO2/95% air (vol/vol), each
functional assay was performed using Victor3 multilabel plate
reader (PerkinElmer, Waltham, MA). Cellular ATP levels were
measured using the ATPLite kit (PerkinElmer) and reactive oxygen
species (ROS) were measured using chloromethyl-2979-dichlorodi-
hydrofluorescein diacetate acetyl ester (CM-H2DCFDA) (Sigma-
Aldrich, St. Louis, MO). Mitochondrial membrane potential
(MMP) was measured using 5,59,6,69-tetrachloro-1,19,3,39-tetra-
ethylbenzimidazolylcarbocyanine iodide (JC-1) dye (Molecular
Probes, Carlsbad, CA) and cellular viability and mitochondrial
dehydrogenase activity were measured by the 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich,
St. Louis, MO) reduction assay.
Statistical analysis of functional measurements
Data are expressed as the mean 6 SE. Significant differences
between groups were evaluated using the Mann-Whitney test.
Differences were considered statistically significant when p-values
were ,0.05. Statistical analyses were performed using SPSS 12.0
software for Windows (SPSS Inc., Chicago, IL).
Microarray experiments
Isolation of total RNA from cells was performed using the
RNeasy Micro Kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. Targets for the GeneChip Human
Gene 1.0 ST Array (Affymetrix, Santa Clara, CA) were prepared
and hybridized with the GeneChip Whole Transcript Sense
Target Labeling Assay (Affymetrix) and scanned according to the
manufacturer’s instructions (Scanner 3000 7G, Affymetrix). The
data of each cybrid were acquired in four replicates. The
microarray data were all MIAME compliant and were deposited
to Gene Expression Omnibus under the accession number
GSE26244.
Microarray data preprocessing
The CEL files were imported to the Affymetrix Expression
Console software and normalized by the Robust Multi-chip
Average method [20] and log2-transformed. Expression data from
probes without gene symbol annotations (based on NetAffx
annotation accessed in November 2008) were discarded. Expres-
sion levels from multiple probes that represent the same gene were
averaged into a single value within each array. Expression data
from four technical replicates from each cybrid were also
averaged, yielding gene-level averaged and replicate-averaged
expression profiles for 20,196 unique genes and 12 cybrid samples,
which were used for all subsequent analyses.
Functional enrichment analysis
Functional enrichment analysis was performed using two
independent methods, gene set enrichment analysis (GSEA) [21]
and GeneTrail [22], to provide more confidence in the findings.
Both of them have advantages in that they can identify functional
categories with subtle but coherent expression changes by
bypassing a cutoff-dependent identification step of differentially
expressed genes. To prepare input data for the functional
enrichment analysis, a sorted list of all genes ranked by Welch t-
statistic was made for each of three pairwise haplogroup
comparisons. Enrichment analyses were calculated under the
pre-ranked mode with 1,000 permutations on GSEA and the gene
set mode on GeneTrail. Since the focus of this study is to identify
metabolic differences between haplogroups, GSEA and GeneTrail
analyses were run against KEGG metabolic pathways only. The
minimum and maximum sizes of gene sets were set to 25 and 500,
respectively, in both analyses. A pathway was considered
significantly regulated if its p-value was ,0.05 and the false
discovery rate was ,0.25, as has generally been done [6].
Differential expression and clustering analysis
To simplify the biological interpretation of results from
differential expression and clustering analysis, only the data from
probes that represent well-characterized genes were used in the
analysis by retaining only the protein-coding or mitochondrially
encoded gene probes that are annotated with the gene symbol and
gene ontology biological process. There were a total of 13,379
such genes.
To identify genes that are differentially expressed between
haplogroups, analysis of variance (ANOVA) followed by Tukey’s
pairwise comparison was performed using R/Bioconductor. Genes
wereconsideredsignificantlydifferentiallyexpressedif p-values from
ANOVA and Tukey’s test were both below 0.05; a total of 2,361
genes met these criteria. Among them, 210 genes also satisfied a
minimum criterion of a 1.2-fold change between haplogroup pairs.
Hierarchical clustering analysis was performed using two
complementary methods: a usual gene-based clustering and a gene
set-based clustering. The gene-based clustering that groups genes
and samples was done using the Genesis [23] software with
expression profile data of 210 differentially expressed genes that
satisfy both statistical and fold change criteria. The gene set-based
clustering that groups gene sets and samples was done on the
PathCluster [24] software with expression profile data of 2,361
differentially expressed genes that satisfy statistical significance only.
In accordance with the focus of this study, PathCluster analysis was
run against KEGG metabolic pathways only. The minimum gene
set size was set to 3. In both clustering analyses, the expression
profile of each gene was standardized with a z-transformation such
that the row mean becomes 0 and the row variance becomes 1, and
hierarchical clustering was done using average linkage clustering
with Pearson centered correlation as a similarity metric.
Results
Mitochondrial functions in cybrid cells harboring
different mtDNA haplogroups
We examined the mitochondrial functions of cybrids harboring
mtDNA haplogroups D5, F, and N9a. Mitochondrial function was
assessed in terms of ATP production, ROS generation, MMP, and
cellular dehydrogenase activity. There were no significant
differences in these assays among the three haplogroups examined
(Figure 2).
Haplogroup comparison by differential expression
analysis
We examined differential gene expression among the three
haplogroups. A total of 2,361 genes met the p-value cutoff ,0.05
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satisfied the pairwise fold-change criterion .1.2-fold (listed in File
S1). Figure 3A shows the number of differentially expressed genes
and their overlap, where the smallest was found in the D5 vs. F
comparison, suggesting a similarity in the gene expression
signature between haplogroups D5 and F.
Clustering of expression profile
The expression profile of the 210 genes obtained above was
subjected to hierarchical clustering (Figure 3B). All samples but F-
2 were clustered according to their haplogroup assignments.
Haplogroups D5 and F were grouped together, with haplogroup
N9a being separated by a large inter-cluster branch length. Next,
we analyzed the expression profile of 2,361 genes from the
ANOVA analysis by a metabolic pathway-based hierarchical
clustering using PathCluster (Figure 3C), which showed a similar
pattern of clustering to that shown in Figure 3B.
Haplogroup comparison by gene set enrichment analysis
on metabolic pathways
We compared gene expression levels of metabolic pathways
between the three mtDNA haplogroups using GSEA, which
reveals coordinated transcriptomic alterations of gene sets [21].
Several metabolic pathways showed differential expression be-
tween the three mtDNA haplogroups (Table 1). When hap-
logroups D5 and F were compared, only the N-glycan biosynthesis
pathway showed differential expression. When haplogroups N9a
and D5 were compared, only the arachidonic acid metabolism
pathways were differentially expressed. In the comparison of N9a
and F, haplogroup F showed up-regulation of glycolysis/
gluconeogenesis and down-regulation of three pathways: N-glycan
biosynthesis, propanoate metabolism, and OXPHOS. The up-
regulation of the glycolysis/gluconeogenesis pathway is thought to
be attributable to glycolysis since the expression levels of key
enzymes in gluconeogenesis (PC, PCK1, PCK2, FBP1, FBP2, and
G6PC) were insignificant with a fold-change range of 1.02–1.13
and a p-value range of 0.07–0.59. To further substantiate the
GSEA analysis result, we also repeated the analysis using
GeneTrail [22], which is similar to GSEA in that it is also a
cutoff-free enrichment analysis method. The GeneTrail result was
similar to the GSEA result (Table S2). In particular, all metabolic
pathways in Table 1 were also found to be significantly regulated
by GeneTrail, with even smaller p-values.
To see whether nuclear genes or mitochondrial genes were
responsible for the observed up-regulation of OXPHOS in
haplogroup N9a under its comparison with haplogroup F, we
present the list of OXPHOS genes in the leading-edge subset (the
core set of genes that contribute the most to the differential
regulation of the pathway) (Figure 4) [21]. As shown in Figure 4,
both nuclear and mitochondrial genes (45 genes) were responsible
for the up-regulation of OXPHOS. In addition, the OXPHOS
pathway showed a small down-regulation driven by 16 nuclear
genes, which may be due to a homeostatic response in which the
up-regulation of one component in a pathway leads to the down-
regulation of another component in that pathway in an attempt to
compensate [25].
Discussion
In this study, we investigated functional consequences of three
mtDNA haplogroups (D5, F, and N9a), which are known to be
associated with differential risk of T2DM in both Koreans and
Japanese, by adopting the cybrid model. We found that
mitochondrial functions, as measured by ATP generation, ROS
production, MMP, and cellular viability and dehydrogenase
activity, did not vary among the three haplogroups. Previous
studies have experimentally assessed functional differences caused
Figure 2. Assessment of mitochondrial function of cybrids harboring three mtDNA haplogroups. ATP, ROS, MMP, and MTT assays were
performed. Each experiment was repeated five times. Data are presented as the mean 6 SE.
doi:10.1371/journal.pone.0022116.g002
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results. In one study, no bioenergetic differences were found
between haplogroups H and T in terms of mitochondrial and
cellular respiration rates, coupling efficiency, and MMP [26]. In
another study, some functional differences were found between
haplogroups H and Uk, such as MMP, growth capacity, and
normalized oxygen consumption [27]. These inconsistent results
suggest that some mtDNA haplogroups may be functionally
neutral and others not. Alternatively, modest functional difference
may be fully compensated by the nuclear genome, but under
certain circumstances, this compensation may be not enough for
maintaining normal cellular function.
Gene expression studies have demonstrated that the nuclear
genome responds to impaired mitochondrial functions that arise
from the depletion of mtDNA [28] or the mutation of mtDNA,
such as A3243G [29]. Although we could not find robust
functional differences in the mitochondrial function of cybrids,
we investigated the genome-wide expression profile of cybrids by
microarray to find possible compensatory mechanisms at the
genomic level. Differential expression and cluster analyses revealed
some evidence of nuclear genomic responses, which may be
attributable to each mtDNA haplogroup tested in this study. First,
even though an identical nuclear genomic background is shared
among cybrids, pair-wise comparisons between cybrids with
different mtDNA haplogroups exhibited a number of differentially
expressed nuclear genes (Figure 3A), suggesting that nuclear gene
expression is altered in response to possible differences in
mitochondrial function related to different mtDNA haplogroups.
Second, cybrids were clustered similarly according to mtDNA
haplogroups when the cluster analysis was repeated using two
types of expression profiles: the individual gene-level expression
(Figure 3B) and the metabolic pathway-level expression
(Figure 3C). Since the latter expression profile was derived solely
from metabolic genes, the agreement of the two clustering analyses
indicates that differences in metabolic transcriptome may be the
main feature that distinguishes the three mtDNA haplogroups
from one another.
It is noteworthy that the similarity in transcriptional responses
elicited by different mtDNA haplogroups correlates with their
reported susceptibility to T2DM. First, the number of differentially
expressed genes was the smallest in the D5 vs. F comparison
(Figure 3A), both of which are associated with an increased risk for
T2DM (odds ratio 1.33 [95% CI 1.00–1.76] p=0.0475, odds ratio
1.34 [95% CI 1.07–1.67] p=0.0114, respectively [10]). However,
when either D5 or F was compared to N9a, which is associated
with a decreased risk for T2DM (odds ratio 0.55 [95% CI 0.40–
0.75] p=0.0002 [10]), more differential gene expression was
observed than in the D5 vs. F comparison (Figure 3A). Second,
haplogroups D5 and F were clustered together, whereas
haplogroup N9a was separated from them by a large inter-cluster
branch length (Figure 3B). Taken together, the possible alteration
in mitochondrial function related to diabetes-susceptible mtDNA
haplogroups (D5 and F) and the diabetes-resistant mtDNA
haplogroup (N9a) may elicit distinct transcriptional responses in
the nuclear genome. In this regard, it is worthy to note that
mtDNA haplogroups N9a, F, and D are characterized by non-
synonymous single nucleotide polymorphisms (SNPs): Thr8Ala in
ND5 (N9a), Ser531Thr in ND5 (F), and Leu237Met in ND2 (D5)
[10]. To assess the functional effect of the amino acid substitution
shown above, we used the PolyPhen-2 program [30]. The
Table 1. Significant differentially expressed metabolic pathways identified from haplogroup comparisons using GSEA.
Comparison Pathway ID Pathway name NES
Nominal
p-value
FDR
q-value
D5 vs. F Less active in D5 (More active in F)
None
More active in D5 (Less active in F)
HSA00510 N-Glycan biosynthesis 1.99 0.000 0.007
N9a vs. D5 Less active in N9a (More active in D5)
HSA00590 Arachidonic acid metabolism 21.42 0.049 0.235
More active in N9a (Less active in D5)
None
N9a vs. F Less active in N9a (More active in F)
HSA00010 Glycolysis and gluconeogenesis 21.59 0.002 0.230
More active in N9a (Less active in F)
HSA00510 N-Glycan biosynthesis 1.92 0.000 0.015
HSA00640 Propanoate metabolism 1.53 0.023 0.213
HSA00190 Oxidative phosphorylation 1.46 0.014 0.249
Criteria for significance are nominal p-value ,0.05 and FDR q-value ,0.25. Core sets of genes for these pathways are listed in Table S1. Abbreviations: NES—normalized
enrichment score, FDR—false discovery rate.
doi:10.1371/journal.pone.0022116.t001
Figure 3. Results from differential expression and clustering analyses. (A) Three-way Venn diagrams that show the number of differentially
expressed genes that are in common or specific to each of the amongthree mtDNA haplogroups. Left—Venn diagram of 2,361 genes that were
statistically significant; Right—Venn diagram of 210 genes with more than 1.2-fold pairwise change as well as being statistically significant. (B)
Hierarchical clustering of 12 cybrids using the expression profile of 210 genes. (C) Metabolic pathway-based hierarchical clustering of 12 cybrids using
PathCluster. Five pathways in blue indicate the metabolic pathways in Table 1 whose differential regulation were found to be statistically significant
by GSEA analysis.
doi:10.1371/journal.pone.0022116.g003
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predicted as ‘‘possibly damaging’’ (i.e., affecting protein function):
ND5 in haplogroup F with a score of 0.205 (sensitivity: 0.90;
specificity: 0.83), and ND2 in haplogroup D5 with a score of 0.364
(sensitivity: 0.88; specificity: 0.85). The substitution at ND5 in
haplogroup N9a did not yield a score since this substitution occurs
at a position bearing no homology in the family of homologous
proteins. Thus, the PolyPhen-2 analysis provides some supporting
evidence that the substitutions observed at ND5 in haplogroup F
and at ND2 in haplogroup D5 may be functional, whereas the
substitution observed at ND5 in haplogroup N9a may be neutral.
By pathway analysis with GSEA, we identified several metabolic
pathways that were differentially expressed between haplogroups
(Table 1), including four pathways that were identified between
haplogroups N9a and F. Notably, haplogroup F showed a
decreased expression of the OXPHOS pathway and an increased
expression of the glycolysis pathway. This observation can be
regarded as a compensatory response for decreased ATP
production caused by a defective mtDNA haplogroup, resulting
in an increased expression of nuclear genes involved in glycolysis.
GeneTrail analysis also exhibited a similar result. The pathway-
level comparison of haplogroups N9a and F also revealed
differential regulation of N-glycan biosynthesis and propanoate
metabolism, where activities of both pathways were higher in N9a
than in F. Further studies are required to examine the role of N-
glycan biosynthesis and propanoate metabolism under abnormal
mitochondrial function.
There are certain limitations in this study. We note that the
apparent absence of differences in mitochondrial functions
between the mtDNA haplogroups, as measured by biochemical
experiments, might arise from the limited sample size of our study
and the inability to detect very small functional changes. In
addition, the use of the osteosarcoma-derived rho
0 cell line
prevented us from assessing mitochondrial functions in diabetes-
relevant tissues, such as muscle, fat, liver, and pancreatic islets.
In summary, cybrids comprised of T2DM-associated mtDNA
haplogroups did not show measurable differences in mitochondrial
function. However, microarray analysis revealed differences in the
expression of nuclear genes. Most notably, cybrids harboring the
T2DM-susceptible F haplogroup exhibited significant differences
in their gene expression profile at the pathway level compared to
the T2DM-resistant N9a haplogroup. This suggests an important
cross-talk between the mitochondria and the nucleus, where
variation in mtDNA could affect expression of nuclear genes
regulating mitochondrial function or cellular energetics. In this
regard, we speculate that the defective nuclear compensation for
impaired mitochondrial function caused by mtDNA factors may
lead to functional alterations at the cellular level for certain nuclear
and/or environmental factors (e.g., aging). Future studies are
needed to identify the key signals mediating mitochondria-nuclear
communication.
Supporting Information
File S1 Lists of 210 differentially expressed genes that satisfied
both the statistical significance criterion and pairwise fold change
criterion .1.2-fold.
(XLS)
File S2 Detailed method of cell-based functional measurements.
(DOC)
Table S1 Genes that contribute the most to the differential
regulation of metabolic pathways listed in Table 1. Genes that
contribute the most to the differential regulation of metabolic
pathways listed in Table 1.
(DOC)
Table S2 Significant differentially regulated metabolic pathways
identified from haplogroup comparisons using GeneTrail.
(DOC)
Figure 4. GSEA enrichment plot for oxidative phosphorylation in the comparison of N9a vs. F haplogroups. The plot shows that
OXPHOS pathway is overall more active in haplogroup N9a than in haplogroup F. Each of the black peaks represent a gene in the OXPHOS pathway.
There are a total of 125 OXPHOS genes. The 45 genes within the red double-headed arrow are the genes that contribute the most to the overall up-
regulation of OXPHOS. Note that OXPHOS is also down-regulated to some degree. The 16 genes within the blue double-headed arrow are down-
regulated the most.
doi:10.1371/journal.pone.0022116.g004
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